Abbott To Acquire Facet Biotech
Abbott has agreed to acquire Facet Biotech for $27 per share in cash for a net transaction value of approximately $450m to enhance its early- and mid-stage pharmaceutical pipeline.
Recommended Vendors
FDA What’s New
World Pharma
- Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication SAPHRIS®
- Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
- Bristol-Myers Squibb to Acquire ZymoGenetics
- Roche announces Operational Excellence initiative